Home page | Personnel | Projects | Presentations | Publications

---

This page contains a list of REVIEW ARTICLES.
Click here for a list of JOURNAL ARTICLES GROUPED ACCORDING TO SUBJECT.
Click here for a CHRONOLOGICAL LIST OF JOURNAL ARTICLES.

Links to PubMed and to downloadable PDF files are included, if available.

Tollefsen DM
CAP consensus conference XXXVI: Diagnostic issues in thrombophilia: Heparin cofactor II deficiency.
Arch Pathol Lab Med 2002 Nov;126(11):1394-400 [Reprint PDF 184 KB]

Tollefsen DM
Heparin cofactor.
In "Wiley Encyclopedia of Molecular Medicine, Volume 3" (Creighton TE, ed.), John Wiley & Sons, New York, pp. 1591-1593 (2002)

Majerus PW, Tollefsen DM
Anticoagulant, thrombolytic, and antiplatelet drugs.
In "Goodman & Gilman's The Pharmacological Basis of Therapeutics, 10th Edition" (Hardman JG, Limbird LE, Molinoff PB, Gilman AG, eds.), McGraw-Hill, New York, pp. 1519-1538 (2001)

Tollefsen DM
Antithrombin deficiency.
In "The Metabolic and Molecular Bases of Inherited Disease, 8th Edition" (Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B, eds.), McGraw-Hill, New York, pp. 4455-4471 (2001) [Preprint PDF 220 KB]

Broze GJ Jr, Tollefsen DM
Regulation of blood coagulation by protease inhibitors.
In "The Molecular Basis of Blood Diseases, 3rd Edition" (Stamatoyannopoulos G, Majerus PW, Perlmutter RM, Varmus H, eds.), W. B. Saunders Co., Philadelphia, pp. 657-679 (2001)

Crowther MA, Ginsberg JS, Tollefsen DM, Blinder MA
Heparin.
In "Hematology:  Basic Principles and Practice, 3rd Edition" (Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, McGlave P, eds.), Churchill Livingstone, New York, pp. 2046-2056 (2000)

Tollefsen DM
Heparin cofactor II
Adv Exp Med Biol 1997;425:35-44

Majerus PW, Broze GJ Jr, Miletich JP, Tollefsen DM
Anticoagulant, thrombolytic, and antiplatelet drugs.
In "The Pharmacological Basis of Therapeutics, 9th Edition" (Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, eds.), McGraw-Hill, New York, pp. 1341-1359 (1996)

Tollefsen DM
Insight into the mechanism of action of heparin cofactor II
Thromb Haemost 1995 Nov;74(5):1209-14

Tollefsen DM
Antithrombin deficiency.
In "The Metabolic and Molecular Bases of Inherited Disease, 7th Edition" (Scriver CR, Beaudet AL, Sly WS, Valle D, eds.), McGraw-Hill, New York, pp. 3313-3334 (1995; CD-ROM update 1996)

Tollefsen DM, Blinder MA
Heparin.
In "Hematology: Basic Principles and Practice, 2nd Edition" (Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ, Silberstein, LE, eds.), Churchill Livingstone, New York, pp. 1802-1813 (1995)

Tollefsen DM
The interaction of glycosaminoglycans with heparin cofactor II
Ann N Y Acad Sci 1994 Apr 18;714:21-31

Broze GJ Jr, Tollefsen DM
Regulation of blood coagulation by protease inhibitors.
In "The Molecular Basis of Blood Diseases, 2nd Edition" (Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H, eds.), W. B. Saunders Co., Philadelphia, pp. 629-656 (1994)

Tollefsen DM
Heparin cofactor II.
In "Human Protein Data" (Haeberli A, ed.), VCH Verlagsgesellschaft mbH, Weinheim (1992; updated 1997)

Tollefsen DM
The interaction of glycosaminoglycans with heparin cofactor II: structure and activity of a high-affinity dermatan sulfate hexasaccharide
Adv Exp Med Biol 1992;313:167-76

Van Deerlin VM, Tollefsen DM
Molecular interactions between heparin cofactor II and thrombin
Semin Thromb Hemost 1992;18(3):341-6

Tollefsen DM
Heparin: basic and clinical pharmacology.
In "Hematology: Basic Principles and Practice" (Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ, eds.), Churchill Livingstone, New York, pp. 1436-1445 (1991)

Majerus PW, Broze GJ Jr, Miletich JP, Tollefsen DM
Anticoagulant, thrombolytic, and antiplatelet drugs.
In "The Pharmacological Basis of Therapeutics, 8th Edition" (Gilman AG, Rall TW, Nies AS, Taylor P, eds.), Pergamon Press, New York, pp. 1311-1331 (1990)

Tollefsen DM
Laboratory diagnosis of antithrombin and heparin cofactor II deficiency
Semin Thromb Hemost 1990 Apr;16(2):162-8

Tollefsen DM, Maimone MM, McGuire EA, Peacock ME
Heparin cofactor II activation by dermatan sulfate
Ann N Y Acad Sci 1989;556:116-22

Tollefsen DM
Disorders of hemostasis.
In "Manual of Medical Therapeutics, 26th Edition" (Dunagan WC, Ridner ML, eds.), Little, Brown and Co., Boston, pp. 326-340 (1989)

Tollefsen DM
Heparin cofactor II.
In "Heparin: Chemical and Biological Properties, Clinical Applications" (Lane DA, Lindahl U, eds.), Edward Arnold, London, pp. 257-273 (1989)

Tollefsen DM
Antithrombin deficiency.
In "The Metabolic Basis of Inherited Disease, 6th Edition" (Scriver CR, Beaudet AL, Sly WS, Valle D, eds.), McGraw-Hill, New York, pp. 2207-2218 (1989)

Tollefsen DM
Structure and function of heparin cofactor II.
ISI Atlas of Science: Biochemistry 1: 19-24 (1988)

Tollefsen DM
Disorders of hemostasis.
In "Manual of Medical Therapeutics, 25th Edition" (Orland MJ, Saltman RJ, eds.), Little, Brown and Co., Boston, pp. 271-283 (1986)

Tollefsen DM
Activation of heparin cofactor II by heparin and dermatan sulfate
Nouv Rev Fr Hematol 1984;26(4):233-7

Shuman MA, Majerus PW, Tollefsen DM
Thrombin generation during hemostasis.
In "First Florence Conference on Hemostasis and Thrombosis" (Neri Serneri GG, Prentice CRM, eds.), Academic Press, New York, pp. 91-101 (1979)

Majerus PW, Tollefsen DM, Shuman MA
The interaction of platelets with thrombin.
In "Platelets in Biology and Pathology" (Gordon JL, ed.), Elsevier/North Holland Biomedical Press, New York, pp. 241-260 (1976)